R168 - Oral, Club Mex-H Anticorps monoclonal CL1-R2 anti-CD160 : un agent thérapeutique anti-tumoral innovant
Chabot, S., Tabiasco, J., Thuéry, A., Aguerre, M., Meggetto, F., Giuriato, S., Malecaze, F., Bensussan, A., Le Bouteiller, P., Jabrane-Ferrat, N.Volume:
97
Language:
french
Journal:
Bulletin du Cancer
DOI:
10.1016/S0007-4551(15)31089-4
Date:
October, 2010
File:
PDF, 74 KB
french, 2010